QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Selecting Risk Minimisation Measures in Practice under GVP Module XVI

Test your understanding of the concepts covered by GVP Module XVI: Selecting Risk Minimisation Measures in Practice.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate starting point when selecting a risk-minimisation measure?

Select a familiar tool and then adapt the safety problem to it Define how the harm occurs and what must change to reduce it Choose the most restrictive available control Begin by assessing whether the material can be distributed digitally

Question 2 of 10 An educational guide reaches 95% of target prescribers, but appropriate monitoring does not improve. What is the most appropriate interpretation?

The RMM is effective because distribution exceeded 90% The RMM is ineffective solely because the adverse reaction rate is unknown Implementation reach is demonstrated, but the targeted behavioural effect has not been demonstrated The guide should automatically be replaced by a restricted-distribution programme

Question 3 of 10 What is the principal advantage of defining the evaluation plan prospectively?

It guarantees that the RMM will be effective It allows the organisation to define objectives, indicators, data sources and interpretation before results are needed It eliminates the need for baseline or comparator information It permits evaluation to focus only on distribution metrics

Question 4 of 10 What should documentation of an RMM selection decision demonstrate?

Only that the selected tool has been used successfully for another medicine The relationship between the risk, objective, target behaviour, selected intervention and justification for routine or additional measures That the most burdensome available intervention was considered preferable That distribution arrangements were finalised before the risk was characterised

Question 5 of 10 A checklist is proposed for a risk that depends on completing several laboratory and contraindication checks before prescribing. Under which condition is the checklist most likely to be useful?

It is available at the point of prescribing and is understood and used It is distributed once, regardless of whether prescribers use it It contains every possible safety topic for the medicine It is kept centrally but not integrated into the prescribing workflow

Question 6 of 10 What is a key expectation for a direct healthcare-professional communication used as part of risk minimisation?

It should promote increased use of the medicine in eligible patients It should communicate the safety issue and required action without overstating the evidence It should replace the approved product information It should be sent to every healthcare professional irrespective of relevance

Question 7 of 10 Which consideration is least consistent with a proportionate decision to introduce an additional risk-minimisation measure?

The seriousness and preventability of the risk The feasibility of the intervention in the relevant healthcare setting The residual risk not adequately addressed by routine measures Whether a similar product already uses the same educational tool

Question 8 of 10 How should EU-level risk-minimisation objectives and national implementation generally relate to one another?

National implementation may change the scientific safety objective according to local preference The scientific objective should remain consistent while implementation may follow national systems, languages and competent-authority processes National authorities have no role once an EU strategy is established Each Member State should use a different objective to reflect its healthcare system

Question 9 of 10 Why should clinical outcome indicators be interpreted cautiously after implementation of an RMM?

Clinical outcomes are never relevant to risk minimisation Outcome frequency may be influenced by exposure, disease severity, reporting behaviour and other factors Clinical outcomes are always less informative than distribution data A reduction in outcomes automatically proves that the RMM caused the change

Question 10 of 10 Which statement best describes the MAH's responsibility when vendors or affiliates perform operational RMM activities?

Responsibility transfers entirely to the contracted vendor The MAH remains responsible for governance, oversight and regulatory compliance while operational tasks may be delegated The QPPV must personally perform all distribution and data-collection activities Contracts alone provide sufficient evidence of effective oversight

QPPV.com

Knowledge Assessment: Selecting Risk Minimisation Measures in Practice under GVP Module XVI

Cookie Settings